EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical Outcome and Surgical Outcome of Moyamoya Disease after Combined Revascularization Performed at the Neurological Institute of Thailand

Sarunya Yuthagovit, Punjama Lertbutsayanuku, Wuttipong Tirakotai

Asian Journal of Neurosurgery · 01.03.2025 · 20 (01) · 075-081

DOI: 10.1055/s-0044-1792159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Neurosurgery, erschienen am 01.03.2025. Verfasst von Sarunya Yuthagovit und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Neurological Institute of Thailand, Bangkok, Thailand. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Moyamoya disease is a chronic, progressive, intracranial steno-occlusive disease. Cerebral revascularization has proved that it is more beneficial than medical therapy for prevention of recurrent stroke. We aimed to report clinical and surgical outcome of moyamoya disease after combined revascularization in Thai population. Materials and Methods From October 2015 to March 2023, patients diagnosed with moyamoya disease and were operated with combined revascularization were included. Patients were evaluated for hemodynamic state with preoperative and postoperative blood oxygenation level-dependent magnetic resonance (BOLD MR) imaging. Demographic data, serial imaging, surgical outcome, and clinical outcome were analyzed. Morbidity and mortality rates of surgery were reported. For clinical outcome evaluation, modified Rankin Scale (mRS) scores were compared between preoperative and postoperative outcome. The mRS score of 0 to 2 signify good outcome after surgery.

Results

There were a total of 55 patients. Ischemic stroke was the most common presentation (87.3%). Based on the Suzuki's classification, most of the patients were stage 3 and 4. Clinical outcome measured with mRS score had good outcome, 100% (mRS score 0–2). For surgical outcome, overall graft patency was 94.8%, overall complication rate was 6.5%, and mortality rate was zero. Mean follow-up duration was 44.5 ± 25.1 months. Recurrent stroke occurred in 1.3%, which was recurrent ischemic stroke.

Conclusion

Combined revascularization in moyamoya disease in the Thai population has a good clinical outcome, an acceptable risk of complication, and a reduced recurrent rate of stroke. Clinical and surgical outcome should be studied in the long term with the use of BOLD MR with carbon dioxide stimuli for the evaluation of cerebral blood flow in the patient.

Schlagwörter

Stichwörter der Autor:innen

BOLD MRThai populationclinical outcomecombined revascularizationmoyamoya diseasesurgical outcome

Autor:innen und Institutionen

  • Department of Neurosurgery, Neurological Institute of Thailand, Bangkok, Thailand.
  • Department of Neuroradiology, Neurological Institute of Thailand, Bangkok, Thailand.

Zitieren

APA

Yuthagovit, S., Lertbutsayanuku, P., & Tirakotai, W. (2025). Clinical Outcome and Surgical Outcome of Moyamoya Disease after Combined Revascularization Performed at the Neurological Institute of Thailand. Asian Journal of Neurosurgery, 20(01), 075-081. https://doi.org/10.1055/s-0044-1792159

Vancouver

Yuthagovit S, Lertbutsayanuku P, Tirakotai W. Clinical Outcome and Surgical Outcome of Moyamoya Disease after Combined Revascularization Performed at the Neurological Institute of Thailand. Asian Journal of Neurosurgery. 2025;20(01):075-081. doi:10.1055/s-0044-1792159

BibTeX
@article{Yuthagovit2025,
  author = {Yuthagovit, Sarunya and Lertbutsayanuku, Punjama and Tirakotai, Wuttipong},
  title = {Clinical Outcome and Surgical Outcome of Moyamoya Disease after Combined Revascularization Performed at the Neurological Institute of Thailand},
  journal = {Asian Journal of Neurosurgery},
  year = {2025},
  volume = {20},
  number = {01},
  pages = {075--081},
  doi = {10.1055/s-0044-1792159}
}
Kostenlos starten →